Patients' osteometabolic control improves the management of medication-related osteonecrosis of the jaw.

Osteonecrosis of the jaws (ONJ) represents a concern for patients taking antiresorptive drugs. The aim of this study was to test the hypothesis that preoperative individualized pharmacological control of the patient's osteometabolic profile could lead to predictable healing of the surgically treated region and minimize the incidence of complications.

from Imaging via alkiviadis.1961 on Inoreader http://ift.tt/2yCDO54